Article Details
Retrieved on: 2018-03-20 04:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc. raised its stake in Gilead Sciences by 2.4% during the 2nd quarter. <b>Vanguard Group</b> Inc. now owns 92,841,960 shares of the biopharmaceutical company's stock valued at $6,571,355,000 after purchasing an additional 2,148,697 shares during the last quarter. Bank of New York ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here